An Initiative of the City of Akron

Success Stories

Sterionics | NicheVision | FMI Technologies | Summit Data Communications | 7signal | Nervomatrix | Quest Medical Imaging | Adjuvant Polymers | APTO Orthopaedics | Intellirod Spine | Nervive | OES Plus | Timocco



Revolutionizing Psoriasis Care

Fluence Therapeutics, Inc. is introducing a new photodynamic therapy (PDT) treatment for psoriasis. This new treatment will provide relief from psoriasis without extreme cost or adverse side effects. Unlike traditional systematic presciption drugs and light therapy, Fluence's innovative approach involves using the cancer therapeutic compund Pc 4. The psoriasis market is expected to increase to $6.8 billion by 2019, and technologies such as the one being developed by Fluence Therapeutics will help make psoriasis treatment more effective than ever.